Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
-
-
As reprocessing for cardiac cath lab catheters becomes available, hospitals may be able to save money on more expensive types of devices, including atherectomy systems and FFR catheters. Atherectomy procedure at Henry Ford Hospital in Detroit. Photo by Dave Fornell.
In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get...
-
September 13, 2021 — The European Society of Cardiology (ESC) and European Association for...
-
September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in...
Videos | Congenital Heart | September 15, 2021
Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, explains the importance of the heart team...
Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get...
Non-invasive evaluation of heart valves using echocardiography first, and other cardiac imaging techniques when needed, is the key evaluation of heart valves in the new ESC and European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease. Photo by Dave Fornell.
News | Structural Heart | September 13, 2021
September 13, 2021 — The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (...
Sponsored Content
Case Study | Cardiovascular Information Systems (CVIS) | April 01, 2021
Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in...
News | Sudden Cardiac Arrest | September 13, 2021
September 13, 2021 — Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment...
News | FFR Technologies | September 08, 2021
September 8, 2021 — Adding systematic fractional flow reserve (FFR) assessment to coronary angiography does not reduce...
A 3-D CT reconstructed image showing a narrow lesion at the carotid bifurcation. ACST-2 was the largest trial to compare the long-term effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on stroke in asymptomatic patients with a severely narrowed carotid artery that had not yet caused a stroke. Image by Canon
News | Stroke | September 07, 2021
September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke...
News | Antiplatelet and Anticoagulation Therapies | September 01, 2021
September 1, 2021 — The STOPDAPT-2 ACS trial does not support the use of one month of dual antiplatelet therapy (DAPT)...
The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart attack or stroke in patients with AFib who undergo transcatheter aortic valve replacement (TAVR), according to an ESC late-breaking trial.
News | Antiplatelet and Anticoagulation Therapies | September 01, 2021
September 1, 2021 – The anticoagulant edoxaban (Savaysa) may be just as effective as warfarin for preventing heart...
News | Left Atrial Appendage (LAA) Occluders | August 31, 2021
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA)...
The Abbott Amplatzer Amulet left atrial appendage (LAA) transcatheter occlusion device. It received FDA clearance in August 2021.
News | Left Atrial Appendage (LAA) Occluders | August 16, 2021
August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage...
News | Pulmonary Embolism | August 09, 2021
August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative...
Abbott's new interventional imaging platform powered by Ultreon 1.0 Software is a first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.
News | Optical Coherence Tomography (OCT) | August 05, 2021
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence...
News | EP Lab | July 30, 2021
July 30, 2021 – Innovative Health Inc. announced several new initiatives to increase savings from single-use device...
An IVC filter seen under X-ray, left. Right, two sizes of the Philips excimer laser technology currently on the U.S. market for EP lead extraction. The CO2 laser technology is able to gently ablate scar tissue encasing leads to enable their extraction.
News | Inferior Vena Cava Filters | July 27, 2021
July 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to a...
The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments.
News | FFR Technologies | July 26, 2021
July 26, 2021 – CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the...
